Summary
Highlights
The video begins by introducing gastric and GI medications. It highlights the complexity of the topic but emphasizes its importance. Different receptors are discussed, including M1 (muscarinic), H1 (histamine), and H2 receptors, clarifying that H1 and H2 blockers target different receptors and are not the same.
The discussion then moves to antiemetics and the mechanisms of vomiting. The vomit center in the medulla and the chemoreceptor trigger zone (CTZ) are introduced as the two main pathways. The CTZ is located outside the blood-brain barrier, making it exposed to circulating toxins like bacteria and medications (e.g., chemotherapy drugs) that can induce vomiting. Signals can originate from central pathways (brain: cerebral cortex, brain stem, thalamus, hypothalamus, vestibular system) or peripheral pathways (vagus and splanchnic nerves from the stomach).
The video details the different receptors involved in vomiting. In the CTZ, these include neurokinin 1, dopamine, serotonin, and acetylcholine. When these receptors are triggered, vomiting is induced. The central pathway predominantly involves neurokinin 1 receptors, with Substance P (a neuropeptide and neurotransmitter) binding to neurokinin 1 receptors, leading to nausea and vomiting. The peripheral signals can go directly to the CTZ, or to the central pathway via the vomiting center, or even from the CTZ to the central pathway.
The process of vomiting is explained, starting with the trigger of the vomit center. This leads to reverse peristalsis, where the pyloric sphincter relaxes and opens. The diaphragm and abdominal muscles contract, forcing stomach contents into the esophagus. To prevent aspiration, the glottis closes, and ultimately, vomiting occurs.
The video briefly introduces antiemetic medications and their targets. These include anticholinergics, H1 antihistamines, neuroleptics, prokinetics, and 5HT3 antagonists, each targeting specific receptors to prevent or reduce vomiting.